血管內皮生長因子B(VEGFB)活性蛋白
Active Vascular Endothelial Growth Factor B (VEGFB)
VEGF-B; VEGFL; VRF; VEGF-Related Factor
- 編號APA144Hu01
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液（pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300）
- 性狀凍干粉
- 純度> 90%
- 等電點-
- 應用Cell?culture;?Activity?Assays.
- 下載 英文說明書 中文說明書
- 規格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1814 ¥ 4536 ¥ 9072 ¥ 27216 ¥ 68040
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
通過ISO 9001、ISO 13485質量體系認證
活性實驗
用法
Reconstitute in 20mM Tris, 150mM NaCl (PH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
增值服務
相關產品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPA144Hu01 | 血管內皮生長因子B(VEGFB)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA144Hu01 | 血管內皮生長因子B(VEGFB)活性蛋白 | Cell?culture;?Activity?Assays. |
| PAA144Hu01 | 血管內皮生長因子B(VEGFB)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA144Hu71 | 血管內皮生長因子B(VEGFB)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| LAA144Hu81 | 血管內皮生長因子B(VEGFB)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
| MAA144Hu22 | 血管內皮生長因子B(VEGFB)單克隆抗體 | WB; IHC; ICC; IP. |
| LAA144Hu82 | 血管內皮生長因子B(VEGFB)單克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
| LAA144Hu72 | 血管內皮生長因子B(VEGFB)單克隆抗體(生物素標記) | WB; IHC; ICC. |
| SEA144Hu | 血管內皮生長因子B(VEGFB)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA144Hu | 血管內皮生長因子B(VEGFB)等多因子檢測試劑盒(流式熒光發光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| International Journal of Cardiology | Reduced microvascular density in non-ischemic myocardium of patients with recent non-ST-segment-elevation myocardial infarction. [PubMed: 22459379] |
| Applied Sciences-Basel | Assessment of annexin A5 and annexin A2 levels as biomarkers for pre-eclampsia: A pilot study [pubmed:29099033] |
| Journal of Endocrinological Investigation | Plasma vascular endothelial growth factor B levels are increased in patients with newly diagnosed type 2 diabetes mellitus and associated with the first phase of glucose-stimulated insulin secretion function of β-cell [10.1007/s40618-017-0677-z] |
| EXCLI Journal | Plasma vascular endothelial growth factor B is elevated in non-alcoholic fatty liver disease patients and associated with blood pressure and renal dysfunction [] |
| Cancer Chemother Pharmacol | Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumors [34164713] |
留言咨詢
